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Objective and Design: to assess if deletion of the angiotensin-converting enzyme (ACE) gene is a risk factor for
abdominal aortic aneurysms (AAAs) in normotensive patients.
Materials and Methods: ACE gene polymorphism was examined by polymerase chain reaction in 124 subjects with
AAA and in 112 control subjects. AAA normotensive patients (group A, n=56) were compared to normotensive control
subjects (group B, n=112) and to AAA hypertensive patients (group C, n=68). All subjects enrolled in this study were
Caucasian and from central and southern Italy.
Results: the distribution of ACE genotypes was: normotensive patients with AAAs (group A): 3 II, 14 ID, 39 DD;
normotensive control subjects (group B): 36 II, 48 ID, 28 DD; hypertensive patients with AAAs (group C): 14 II, 32
ID, 22 DD. The DD genotype was more common in group A than in control groups (A vs B: p<0.001; A vs C: p<0.001).
The ID genotype was more common in group A as well (A vs B: p<0.05; A vs C: p<0.005).
Conclusions: our data suggest a role for ACE I/D gene polymorphism in the pathogenesis of AAA in normotensive
patients.
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Introduction elastase activities found in AAAs are the cause or the
result of aortic dilatation.11 Thus it is possible that
The exact pathogenesis of abdominal aortic aneurysms other genes are also implicated in the pathogenesis of
AAA aorta.(AAAs) has not been completely clarified.1–8 It involves
a series of known and unknown environmental factors Several studies have focused on the relationship
between angiotensin-converting enzyme (ACE) geneacting over time. Hypertension is a documented risk
factor for abdominal aortic aneurysm, as well as age, polymorphism and cardiovascular disease.12,13 ACE
plays an important role in the regulation of bloodmale sex, smoking, and hypercholesterolaemia.6
Nevertheless, AAAs often occur in subjects not affected pressure and vascular tone, by catalysing the con-
version of angiotensin I to angiotensin II, and also byby hypertension and considered to be at low risk. A
positive family history in a first-degree relative is a inactivating bradykinin, a vasodilator and inhibitor of
vascular smooth muscle cell proliferation which canrisk factor for AAAs9,10 and the familial clustering of
the disease suggests a genetic basis. Genes coding for stimulate the release of nitric oxide and prosta-
cyclin.14,15 However, angiotensin II may play a pres-matrix components or connective tissue proteases and
antiproteases are considered potential candidates, but sure-independent role on the arterial wall, mainly by
modifying cell growth or synthesis of the extracellulartheir role in the development of AAA remains to be
determined. Moreover, it is not clear whether the lack matrix.16 Moreover, clinical pharmacological studies
have shown that ACE inhibitors improve stiffnessof collagen and elastin and the high collagenase and
and structure of large arteries independently of blood
pressure reduction and the renin-angiotensin system
∗ Please address all correspondence to: E. Gaetani, Medical Path- plays a major role in the structural and functionalology Institute, Catholic University of the Sacred Heart, Policlinico
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plasmatic and cellular angiotensin-converting enzyme in a few minutes, repeated once a week for three
times or more. After a complete physical examination,are genetically determined.18,19 Two different alleles
of the ACE gene can be identified by the presence medical history, including smoking habit and drug
treatment was collected for all patients. Body mass(insertion, I) or the absence (deletion, D) of a 287 bp
sequence in intron 16, resulting in three genotypes, index (BMI) was calculated as body weight divided
by the square of height (kg/m2). Peripheral venousDD, ID and II. The DD genotype is associated with
increased levels of circulating ACE.18,20 blood samples were taken for determination of lipid
profile as well as for angiotensin-converting enzymeNumerous studies have shown a significant re-
lationship between ACE I/D gene polymorphism and gene polymorphism analysis. Hyperlipidaemia was
defined as either a need for hypolipidaemic drugs, aa wide spectrum of cardiovascular diseases and pre-
vious findings have shown that the DD genotype is a total plasma cholesterol higher than 5.18 mmol/l or
triglycerides higher than 1.94 mmol/l.candidate gene for the development of atherosclerosis21
and has been associated with a high degree of aortic
atherosclerosis22 and with arterial intimal medial thick-
ness.23 This study was designed to assess the con- Sample preparation and PCR detection of ACE DNA
tribution of the ACE I/D gene polymorphism in the polymorphism
development of AAA in normotensive patients. We
therefore decided to examine and compare the dis- Nucleic acid isolation from 5 ml of peripheral blood
tribution of ACE genotypes between normotensive samples was carried out by using a DNA extraction kit
patients affected by AAAs, hypertensive patients af- (Micromix 660, Talent-Biopsa, Milan, Italy). Genomic
fected by AAAs and normotensive control subjects. DNAs were assayed with polymerase chain reaction
for the detection of ACE gene, using the published
primer set: 5′-CTGGAGACCACTCCCATCCTTTCT-3′
(sense primers) and 5′-GATGTGGCCATCACATT-Materials and Methods
CGTCAGAT-3′ (antisense primers), as described by
Rigat et al.25 Briefly, PCR reaction, containing 10 pmolesSubjects
of each primer, 500 mM dNTPs (Boehringer GmbH,
Mannheim, Germany), 3 mM MgCl2, 10 mM Tris-HClA total of 124 patients affected by AAAs, consecutively
pH 8.4, and 2.5 U of AmpliTaq polymerase (Perkin-accepted in the Department of Internal Medicine and
Elmer, Cetus, Norwalk, CT, U.S.A.) in a final volumeAngiology at ‘‘A. Gemelli’’ University Hospital, were
of 50 l, was performed in a GeneAmp PCR Systemenrolled. Patients were divided into two groups:
9600 (Perkin-Elmer) with the following thermal profile,patients with AAA not associated with hypertension
repeated for 35 cycles: denaturation for 1 min at 95 °C,(group A, n=56) and patients with AAAs associated
annealing for 1 min at 58 °C and extension for 2with hypertension (group C, n=68). A group of 112
min at 72 °C. To exclude the occasional failure of thepatients, matched for age and sex, with no AAAs and
insertion allele in heterozygote DNA amplification,no hypertension, were used as controls (group B). All
specimens that appear to be D/D homozygotes wereindividuals enrolled in this study were Caucasian from
subjected to a second PCR amplification by using acentral and southern Italy and belonged to in-
primer pair that recognises an insertion-specificdependent pedigrees. Informed consent was obtained
sequence.20 The PCR products were electrophoresed infrom all patients.
1.5% agarose gel and visualised by ethidium bromideThe presence or absence of AAAs was assessed by
staining. The I allele corresponded to a 490 bp fragmenthigh-resolution B-mode ultrasonography (Ecocolor-
in the presence of the insertion and the D allele to aDoppler Acuson 128XP/10, U.S.A., with a 4 MHz
190 bp fragment in the absence of the insertion.transducer) and the diagnosis of AAA was formulated
according with the criteria of the Society of Vascular
Surgery and the International Society for Cardio-
vascular Surgery.24 Aortic diameter was measured Statistical analysis
below the origin of renal arteries in all groups. Hyper-
tension was defined as either a systolic blood pressure Demographic and clinical data between the three
groups were compared by Chi-squared test for ca-higher than 140 mmHg, a diastolic pressure higher
than 90 mmHg or current treatment with an anti- tegoric variables and by t-test for continuous variables.
Genotype frequencies were compared by 2×3 Chi-hypertensive drug. The reported values of blood pres-
sure are the mean of three measurements performed squared test.
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Table 1. Demographic and clinical data of Group A, Group B and with hypertension; patients affected by AAAs as-
Group C patients. sociated with hypertension; subjects with no AAAs
and no hypertension.Group A Group B Group C
Normotensive Normotensive Hypertensive Our data suggest that ACE DD and ID genotypes
AAA controls AAA are independent risk factors of AAAs in normotensive
(n=56) (n=112) (n=68)
patients. Our findings complement several other case-
Mean age (yrs) 73±10 71±6∗ 72±9∗ control studies that have reported an association be-
Male gender 50 (89%) 96 (86%)∗ 60 (88%)∗ tween the ACE D allele and a wide spectrum ofBMI (kg/m2)±SD 23±3 24±4∗ 25±3†
cardiovascular diseases.Smoking 43 (77%) 80 (71%)∗ 58 (85%)∗
(former or current) The relationship between ACE I/D gene poly-
Hyperlipidaemia 14 (25%) 56 (50%)§ 30 (44%)† morphism and hypertension is controversial.12,18,26 OurAortic diameter 44±5 17±2‡ 45±5∗
patients were Caucasian, from central and southern(mm)±SD
Italy, and a role of ACE gene polymorphism in the
Group A vs Group B: ∗p= n.s.; § p<0.005; † p<0.0001; Group A vs pathogenesis of hypertension and in favouring theGroup C: ∗p= n.s.; † p<0.05; ‡ p<0.0001.
development of cardiovascular diseases is not clear in
Italian population.27–33 We found that, in the presenceTable 2. Ace genotypes distribution in Group A, Group B and
Group C patients. of an AAA, frequency of the D allele is higher in
patients not affected by hypertension than in those
Genotype Group A Group B Group C
affected by hypertension.Normotensive Normotensive Hypertensive
AAA controls AAA Recently, Hamano et al. did not find a significant
(n=56) (n=112) (n=68) difference in the distribution of ACE genotypes in
patients affected by AAA and controls.34 In our study,DD 39 (70%) 28 (25%) 22 (32%)
ID 14 (25%) 48 (43%) 32 (47%) DD and ID genotypes appear to be independent risk
II 3 (5%) 36 (32%) 14 (21%) factors for abdominal aortic aneurysm. The difference
we found could be explained by the fact that we haveGroup A vs Group B: p=0.001; Group A vs Group C: p=0.001;
Group B vs Group C: p=0.22. studied a population with different ethnic char-
acteristics. Moreover, our attention was focused on
Results patients affected by AAAs without hypertension, and
this is the first report describing the distribution of the
The demographic and clinical data of group A (nor- ACE genotypes in such a population. We acknowledge
motensive AAAs), group B (normotensive controls) that the distribution of ACE alleles in our control
and group C (hypertensive AAAs) are shown in Table group is unusual, when compared to other studies
1. There were no significant differences between performed on the same ethnic group.28–34 A possible
groups A and B in terms of age, sex, smoking, or body explanation could be that our control population is
mass index (BMI). Hyperlipidaemia was more frequent specifically composed by subjects not affected by
in groups B and C. The mean diameter of aortic hypertension and more than 70 years old. A group
aneurysms was no different in group A vs C (44±5 with these characteristics cannot be compared to other
and 45±5 mm, respectively, p=n.s.). control groups previously described. It is possible that
The distribution of ACE genotypes in the three the same selection applies to the normotensive AAA
groups is shown in Table 2. The genotypes in all group. However, both groups were matched for age
groups were in Hardy–Weinberg equilibrium. The dis- and normotensive status. Therefore, we acknowledge
tribution of genotypes was significantly different in the small size of our groups and larger case-control
the normotensive AAA patients as compared to hyper- studies, comparing the prevalence of the genotype in
tensive AAAs as well as controls. groups with and without aneurysm, matched for the
severity of hypertension and eventual pharmacological
therapy, will be recquired to establish the exact re-
lationship between hypertension, D allele, and ab-Discussion
dominal aortic aneurysm.
How DD genotype might predipose to abdominalThis is a retrospective study evaluating the role of
aortic aneurysm is uncertain. Previous findings haveACE I/D gene polymorphism in AAA development.
shown that the DD genotype is a candidate gene forOur study compares frequency and distribution of
the development of atherosclerosis16 and has beenclassic risk factors of AAAs in three different groups
of subjects: patients affected by AAAs not associated associated with a high degree of aortic atherosclerosis17
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